Literature DB >> 11259684

Role of the cytoplasmic tyrosines of beta 1A integrins in transformation by v-src.

T Sakai1, R Jove, R Fässler, D F Mosher.   

Abstract

GD25 cells lacking beta 1 integrins or expressing beta 1A with mutations of conserved cytoplasmic tyrosines (Y783, Y795) to phenylalanine have poor directed migration to platelet-derived growth factor or lysophosphatidic acid when compared with GD25 cells expressing wild-type beta 1A. We studied the effects of v-src on these cells. Transformation with v-src caused tyrosine and serine phosphorylation of wild-type beta1 A but not of Y783/795F doubly mutated beta 1A. v-src-transformed cells had rounded and/or fusiform morphology and poor assembly of fibronectin matrix. Adhesion to fibronectin or laminin and coupling of focal contacts to actin-containing cytoskeleton were preserved in transformed Y783/795F cells but lost on transformation when beta 1A was wild type. Transformed Y783/795F cells also retained ability, albeit limited, to migrate across filters, whereas transformed cells with wild-type beta 1A were unable to transverse filters. Studies of single tyrosine mutants showed that the more important tyrosine for retaining ability to adhere, assemble focal contacts, and migrate is Y783. These results suggest that overactive phosphorylation of cytoplasmic residues of beta 1A, particularly Y783, accounts in part for the phenotype of v-src-transformed cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259684      PMCID: PMC31134          DOI: 10.1073/pnas.240456398

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

2.  Integrins isolated from Rous sarcoma virus-transformed chicken embryo fibroblasts.

Authors:  P Tapley; A Horwitz; C Buck; K Duggan; L Rohrschneider
Journal:  Oncogene       Date:  1989-03       Impact factor: 9.867

Review 3.  Integrin transmembrane signaling and cytoskeletal control.

Authors:  K M Yamada; S Miyamoto
Journal:  Curr Opin Cell Biol       Date:  1995-10       Impact factor: 8.382

4.  Excess early signaling activity inhibits cellular chemotaxis toward PDGF-BB.

Authors:  V Kundra; S Soker; B R Zetter
Journal:  Oncogene       Date:  1994-05       Impact factor: 9.867

Review 5.  Oncogene transformation and the metastatic phenotype.

Authors:  A F Chambers; A B Tuck
Journal:  Anticancer Res       Date:  1988 Sep-Oct       Impact factor: 2.480

6.  Phosphorylation of the beta1 integrin cytoplasmic domain: toward an understanding of function and mechanism.

Authors:  J Mulrooney; K Foley; S Vineberg; M Barreuther; L Grabel
Journal:  Exp Cell Res       Date:  2000-08-01       Impact factor: 3.905

Review 7.  Role of focal adhesion proteins in signal transduction and oncogenesis.

Authors:  E Weisberg; M Sattler; D S Ewaniuk; R Salgia
Journal:  Crit Rev Oncog       Date:  1997

8.  Altered localization and cytoplasmic domain-binding properties of tyrosine-phosphorylated beta 1 integrin.

Authors:  M W Johansson; E Larsson; B Lüning; E B Pasquale; E Ruoslahti
Journal:  J Cell Biol       Date:  1994-09       Impact factor: 10.539

9.  A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS.

Authors:  P Rous
Journal:  J Exp Med       Date:  1911-04-01       Impact factor: 14.307

10.  Modulation of beta1A integrin functions by tyrosine residues in the beta1 cytoplasmic domain.

Authors:  T Sakai; Q Zhang; R Fässler; D F Mosher
Journal:  J Cell Biol       Date:  1998-04-20       Impact factor: 10.539

View more
  25 in total

1.  Transformation of chicken embryo fibroblasts by v-src uncouples beta1 integrin-mediated outside-in but not inside-out signaling.

Authors:  A Datta; Q Shi; D E Boettiger
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

2.  Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.

Authors:  David A Calderwood; Yosuke Fujioka; Jose M de Pereda; Begoña García-Alvarez; Tetsuya Nakamoto; Ben Margolis; C Jane McGlade; Robert C Liddington; Mark H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

3.  Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signaling.

Authors:  Danislav S Spassov; Ching Hang Wong; Natalia Sergina; Deepika Ahuja; Michael Fried; Dean Sheppard; Mark M Moasser
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

4.  p21-activated kinase 4 phosphorylation of integrin beta5 Ser-759 and Ser-762 regulates cell migration.

Authors:  Zhilun Li; Hongquan Zhang; Lars Lundin; Minna Thullberg; Yajuan Liu; Yunling Wang; Lena Claesson-Welsh; Staffan Strömblad
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

Review 5.  Integrin inactivators: balancing cellular functions in vitro and in vivo.

Authors:  Daniel Bouvard; Jeroen Pouwels; Nicola De Franceschi; Johanna Ivaska
Journal:  Nat Rev Mol Cell Biol       Date:  2013-05-30       Impact factor: 94.444

Review 6.  Focal adhesion complex proteins in epidermis and squamous cell carcinoma.

Authors:  Elizabeth K Duperret; Todd W Ridky
Journal:  Cell Cycle       Date:  2013-09-12       Impact factor: 4.534

7.  Beta integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation.

Authors:  Nicholas J Anthis; Jacob R Haling; Camilla L Oxley; Massimiliano Memo; Kate L Wegener; Chinten J Lim; Mark H Ginsberg; Iain D Campbell
Journal:  J Biol Chem       Date:  2009-10-20       Impact factor: 5.157

8.  β1A integrin is a master regulator of invadosome organization and function.

Authors:  Olivier Destaing; Emmanuelle Planus; Daniel Bouvard; Christiane Oddou; Cedric Badowski; Valentine Bossy; Aurelia Raducanu; Bertrand Fourcade; Corinne Albiges-Rizo; Marc R Block
Journal:  Mol Biol Cell       Date:  2010-10-06       Impact factor: 4.138

Review 9.  Src kinases as therapeutic targets for cancer.

Authors:  Lori C Kim; Lanxi Song; Eric B Haura
Journal:  Nat Rev Clin Oncol       Date:  2009-10       Impact factor: 66.675

10.  NPXY motifs in the beta1 integrin cytoplasmic tail are required for functional reovirus entry.

Authors:  Melissa S Maginnis; Bernardo A Mainou; Aaron Derdowski; Elizabeth M Johnson; Roy Zent; Terence S Dermody
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.